Axsome Therapeutics Stock Jumped: April Rally and What It Means for Investors
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Index levels shift due to earnings, valuations, and macro surprises. Knowing the main drivers helps you anticipate potential reversals.
17,383 articlesAxsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
When a major investor dumped million from a high-yield closed-end fund, it sent a clear message about risk, liquidity...
The latest Goldman Sachs retirement survey finds a gap between savers’ targets and retirees’ realities, prompting a c...
As Nvidia prepares to report earnings in May, investors weigh AI momentum against valuation. This practical guide exp...
Bank of America upgrades FedEx to its US 1 List, signaling confidence in the company’s DRIVE plan and a stabilizing l...
Tron’s TRX surged in 2026, yet fresh on-chain data points to a potential correction risk as price outpaces network ac...
Chipotle stock could see meaningful upside as management advances a multi-year expansion plan and digital push, even ...
Delinquencies eased in March to 3.35%, though higher-severity stress remains elevated. FHA loans push delinquency sha...
A new warning about looming physical oil shortages is sending ripples through energy stocks. This article explains wh...
Pi Network remains locked in a narrow trading channel around 17 cents, with key support at 16 cents and resistance ne...
Nebius Group keeps powering higher as AI-driven data centers fuel growth. This article breaks down what’s behind the ...
Doximity is due to report Q4 results after the close, with analysts keyed to FY2027 guidance and margin trajectory as...